Skip to main content

Andrea Vilaplana Blanes

I have a degree in Biochemistry and Biomedical Sciences from the University of Valencia. Currently, I work as a researcher in the Cancer and Hematological Diseases Research Group at VHIR. I am part of the personalized medicine program where we work every day to find new therapeutic and molecular targets and guide patients' treatment according to the molecular alterations of their tumors.

Institutions of which they are part

Administration and Management
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Andrea Vilaplana Blanes

Institutions of which they are part

Administration and Management
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

I have a degree in Biochemistry and Biomedical Sciences from the University of Valencia. Currently, I work as a researcher in the Cancer and Hematological Diseases Research Group at VHIR. I am part of the personalized medicine program where we work every day to find new therapeutic and molecular targets and guide patients' treatment according to the molecular alterations of their tumors.

I studied Biochemistry and Biomedical Sciences degree at the University of Valencia between 2015 and 2019. I arrived in Barcelona in 2019 to start the Master in Translational Research at VHIR together with the Autonomous University of Barcelona.

My professional experience is focused on childhood cancer research. In 2020 I started working as Data Manager / Data Entry in the Pediatric Oncology and Hematology Area of Vall d'Hebron Hospital. Currently, since March 2022, I am part of the Research Group on Childhood Cancer and Hematological Diseases at VHIR, developing research tasks as well as database and project management activities.

My research activity is focused on the search for new biomarkers and molecular alterations in childhood tumors, especially in a specific subtype of solid tumor called neuroblastoma.

Thanks to the incorporation to the group I am a part of numerous national and international projects and research organizations. I am sure that these will help to improve the quality of life and the chances of survival of our patients.

Projects

BEACON-BIO: deep biological characterisation and development of biomarkers for relapsed neuroblastoma

IP: Lucas Moreno Martín-Retortillo
Collaborators: Andrea Vilaplana Blanes, María Rosario Pérez- Torres Lobato
Funding agency: European Science Foundation
Funding: 104500
Reference: BEACON-BIO_FKC_2021
Duration: 01/01/2022 - 30/09/2025

International integrated analysis to identify markers of poor survival in high-risk neuroblastoma

IP: Lucas Moreno Martín-Retortillo
Collaborators: Andrea Vilaplana Blanes, Mariona Morell Daniel
Funding agency: Solving Kids’ Cancer
Funding: 131766.91
Reference: SKC/AEFRM/2020/MORENO
Duration: 02/11/2020 - 01/11/2023

Related news

The study analyzes the impact of COVID-19 on people with rare red blood cell disorders, identifying risk factors for severe forms of the disease.

The association, once again, has shown its commitment to oncological research with a donation of €19,197 to the Cancer and Hematological Diseases Group for Children at VHIR.

The prestigious journal The Lancet has published the results of this study, which is the result of more than 20 years of pre-clinical research and 7 years of patient follow-up.

Related professionals

Sofia Muñoz Del Rio

Sofia Muñoz Del Rio

Administrative Assistant
Accounting and Revenue Unit
Finance Directorate
Read more
Miriam Cristine Vah Machado

Miriam Cristine Vah Machado

Postdoctoral researcher
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
Clara Roig Rabada

Clara Roig Rabada

Research assistant
Research Group of Physical Medicine and Rehabilitation
Read more
Aldo Di  Vito

Aldo Di Vito

Predoctoral researcher
Translational Molecular Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.